Dottikon Es Holding AG
SIX:DESN

Watchlist Manager
Dottikon Es Holding AG Logo
Dottikon Es Holding AG
SIX:DESN
Watchlist
Price: 216.5 CHF Market Closed
Market Cap: 3B CHF
Have any thoughts about
Dottikon Es Holding AG?
Write Note

Dottikon Es Holding AG
Investor Relations

Dottikon Es Holding AG stands as one of Switzerland's understated gems in the realm of fine chemicals and pharmaceuticals. Born from Switzerland's rich tradition of precision and quality, the company operates primarily in the realm of exclusive synthesis, tailored to meet the stringent demands of the pharmaceuticals industry. At its core, Dottikon specializes in hazardous chemical reactions, priding itself on an ability to transform complex chemical processes into high-quality results. This specialization provides a competitive edge, allowing Dottikon to focus on developing innovative and complex molecules which serve as active pharmaceutical ingredients (APIs). It's a business model that not only underscores the company's technical expertise but also its commitment to safety and environmental stewardship, given the heightened risks associated with hazardous materials.

Revenue for Dottikon is chiefly generated from strategic partnerships with major pharmaceutical companies. By offering a unique combination of research and development capabilities coupled with state-of-the-art production facilities, Dottikon caters to bespoke needs, from initial developmental scales to full-fledged commercial production runs. The trust and collaboration between Dottikon and its clients are pivotal, as the company becomes an indispensable partner in the clients’ supply chain. As the pharmaceutical sector continues to evolve and demand for specialized molecules increases, Dottikon’s focus on exclusivity and expertise positions it well within the industry, ensuring steady demand and solidifying its role as a reliable, albeit lesser-known, catalyst in advancing pharmaceutical innovations.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Markus Blocher Dipl. Chem., Dr. sc. nat., Ph.D.
Chairman, CEO & MD
No Bio Available
Ms. Marlene Born Eidg. Dipl.
Chief Financial Officer
No Bio Available
Dr. Urs Brändli
Head of Processes & Technologies
No Bio Available
Mr. Kurt Tripolt
Head of Recruiting & Administration
No Bio Available
Ms. Karin Krause
Head of Human Resources
No Bio Available
Dr. Stephan Kirschbaum Dipl. Chem., Dr. rer. nat.
Head of Business Development
No Bio Available
Dr. Thomas Rosatzin Ph.D.
Head of Purchasing
No Bio Available
Dr. Robert Dahinden
Head of Production
No Bio Available
Dr. Rolf Jens Schaller
Head of Quality Management
No Bio Available

Contacts

Address
AARGAU
Dottikon
Hembrunnstrasse 17
Contacts
+41566168111
www.dottikon.com